Literature DB >> 17555610

Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics?

G Minguet1, J Joris, M Lamy.   

Abstract

There is an increasing body of evidence that volatile anaesthetics protect myocardium against ischaemic insult by a mechanism termed 'anaesthetic preconditioning'. Anaesthetic preconditioning and ischaemic preconditioning share several common mechanisms of action. Since ischaemic preconditioning has been demonstrated in organs other than the heart, anaesthetic preconditioning might also apply in these organs and have significant clinical applications in surgical procedures carrying a high risk of ischaemia-reperfusion injury. After a brief review on myocardial preconditioning, experimental and clinical data on preconditioning in non-cardiac tissues will be presented. Potential benefits of anaesthetic preconditioning during non-cardiac surgery will be addressed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555610     DOI: 10.1017/S0265021507000531

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  8 in total

Review 1.  [Post-mortem organ donation].

Authors:  T Goroll; G Gerresheim; W Schaffartzik; U Schwemmer
Journal:  Anaesthesist       Date:  2015-07       Impact factor: 1.041

2.  Incidence and risk factors for early renal dysfunction after liver transplantation.

Authors:  Patricia Wiesen; Paul B Massion; Jean Joris; Olivier Detry; Pierre Damas
Journal:  World J Transplant       Date:  2016-03-24

3.  No renal protection from volatile-anesthetic preconditioning in open heart surgery.

Authors:  Wacharin Sindhvananda; Krit Phisaiphun; Prut Prapongsena
Journal:  J Anesth       Date:  2012-08-12       Impact factor: 2.078

4.  Tourniquet-induced ischemia-reperfusion injuries during extremity surgery at children's age: impact of anesthetic chemical structure.

Authors:  Ivana Budic; Dusica Pavlovic; Dusanka Kitic; Gordana Kocic; Tatjana Cvetkovic; Dusica Simic; Tatjana Jevtovic-Stoimenov
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

5.  Sevoflurane alleviates LPS‑induced acute lung injury via the microRNA‑27a‑3p/TLR4/MyD88/NF‑κB signaling pathway.

Authors:  Yunfei Wang; Xiaoran Zhang; Jianmin Tian; Guoze Liu; Xiaofang Li; Dan Shen
Journal:  Int J Mol Med       Date:  2019-05-30       Impact factor: 4.101

6.  Donor Preconditioning with Inhaled Sevoflurane Mitigates the Effects of Ischemia-Reperfusion Injury in a Swine Model of Lung Transplantation.

Authors:  Alessandro Bertani; Vitale Miceli; Lavinia De Monte; Giovanna Occhipinti; Valeria Pagano; Rosa Liotta; Ester Badami; Fabio Tuzzolino; Antonio Arcadipane
Journal:  Biomed Res Int       Date:  2021-01-08       Impact factor: 3.411

7.  Remifentanil ameliorates intestinal ischemia-reperfusion injury.

Authors:  Steven S C Cho; Ina Rudloff; Philip J Berger; Michael G Irwin; Marcel F Nold; Wei Cheng; Claudia A Nold-Petry
Journal:  BMC Gastroenterol       Date:  2013-04-22       Impact factor: 3.067

8.  The choice of anaesthesia for glioblastoma surgery does not impact the time to recurrence.

Authors:  Stefan J Grau; Mario Löhr; Valeria Taurisano; Herbert Trautner; Marco Timmer; Stephanie G Schwab; Jürgen Hampl; Thorsten Annecke
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.